Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
📊 Key Statistics
Market Cap$89M
P/E Ratio—
EPS (TTM)—
EPS YoY—
Revenue YoY—
Float—
Short Float %—
Inst. Ownership—
Sector RS—
📈 Fundamentals
ROE—
ROIC—
ROA—
Current Ratio—
Debt/Equity—
Gross Margin—
Net Margin—
Dividend Yield—
Next Earnings—
⚡ Options Summary
Call OI—
Put OI—
P/C Ratio (OI)—
Gamma Environment—
Max Pain—
Call Wall—
Put Wall—
🎯 Analyst Estimates
Consensus Target—
High Target—
Low Target—
Analysts—
Upside/Downside—
📋 Quarterly Financials
| Period |
Revenue |
Rev YoY |
EPS |
EPS YoY |
Gross Margin |
🔥 Recent Options Flow
| Type | Strike | Exp | Size | Premium | Time |
🏛️ Institutional Trades
| Type | Price | Size | Value | Venue | Time |
🏦 Top Institutional Holders
| Institution | Shares | Value | % of Class |